1240 related articles for article (PubMed ID: 30913966)
1. Gut bacteria signaling to mitochondria in intestinal inflammation and cancer.
Jackson DN; Theiss AL
Gut Microbes; 2020 May; 11(3):285-304. PubMed ID: 30913966
[TBL] [Abstract][Full Text] [Related]
2. Microbiota dysbiosis and barrier dysfunction in inflammatory bowel disease and colorectal cancers: exploring a common ground hypothesis.
Yu LC
J Biomed Sci; 2018 Nov; 25(1):79. PubMed ID: 30413188
[TBL] [Abstract][Full Text] [Related]
3. Microbiome and colorectal cancer: Unraveling host-microbiota interactions in colitis-associated colorectal cancer development.
Kang M; Martin A
Semin Immunol; 2017 Aug; 32():3-13. PubMed ID: 28465070
[TBL] [Abstract][Full Text] [Related]
4. The crosstalk between gut bacteria and host immunity in intestinal inflammation.
Yang Q; Wang Y; Jia A; Wang Y; Bi Y; Liu G
J Cell Physiol; 2021 Apr; 236(4):2239-2254. PubMed ID: 32853458
[TBL] [Abstract][Full Text] [Related]
5. Mucosa-associated microbiota dysbiosis in colitis associated cancer.
Richard ML; Liguori G; Lamas B; Brandi G; da Costa G; Hoffmann TW; Pierluigi Di Simone M; Calabrese C; Poggioli G; Langella P; Campieri M; Sokol H
Gut Microbes; 2018 Mar; 9(2):131-142. PubMed ID: 28914591
[TBL] [Abstract][Full Text] [Related]
6. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
Stecher B
Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
[TBL] [Abstract][Full Text] [Related]
7. Dismicrobism in inflammatory bowel disease and colorectal cancer: changes in response of colocytes.
Tomasello G; Tralongo P; Damiani P; Sinagra E; Di Trapani B; Zeenny MN; Hussein IH; Jurjus A; Leone A
World J Gastroenterol; 2014 Dec; 20(48):18121-30. PubMed ID: 25561781
[TBL] [Abstract][Full Text] [Related]
8. Fusobacterium and Enterobacteriaceae: important players for CRC?
Allen-Vercoe E; Jobin C
Immunol Lett; 2014 Dec; 162(2 Pt A):54-61. PubMed ID: 24972311
[TBL] [Abstract][Full Text] [Related]
9. Enteroendocrine Cells: Sensing Gut Microbiota and Regulating Inflammatory Bowel Diseases.
Yu Y; Yang W; Li Y; Cong Y
Inflamm Bowel Dis; 2020 Jan; 26(1):11-20. PubMed ID: 31560044
[TBL] [Abstract][Full Text] [Related]
10. Colitis-induced colorectal cancer and intestinal epithelial estrogen receptor beta impact gut microbiota diversity.
Ibrahim A; Hugerth LW; Hases L; Saxena A; Seifert M; Thomas Q; Gustafsson JÅ; Engstrand L; Williams C
Int J Cancer; 2019 Jun; 144(12):3086-3098. PubMed ID: 30515752
[TBL] [Abstract][Full Text] [Related]
11. Oxygen battle in the gut: Hypoxia and hypoxia-inducible factors in metabolic and inflammatory responses in the intestine.
Singhal R; Shah YM
J Biol Chem; 2020 Jul; 295(30):10493-10505. PubMed ID: 32503843
[TBL] [Abstract][Full Text] [Related]
12. Microbiota regulation of inflammatory bowel disease and colorectal cancer.
Liu Z; Cao AT; Cong Y
Semin Cancer Biol; 2013 Dec; 23(6 Pt B):543-52. PubMed ID: 24071482
[TBL] [Abstract][Full Text] [Related]
13. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
Pedersen G
Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
[TBL] [Abstract][Full Text] [Related]
14. Gut microbiota, inflammatory bowel disease and colorectal cancer.
Quaglio AEV; Grillo TG; De Oliveira ECS; Di Stasi LC; Sassaki LY
World J Gastroenterol; 2022 Aug; 28(30):4053-4060. PubMed ID: 36157114
[TBL] [Abstract][Full Text] [Related]
15. Intestinal microbiota in inflammatory bowel disease: friend of foe?
Fava F; Danese S
World J Gastroenterol; 2011 Feb; 17(5):557-66. PubMed ID: 21350704
[TBL] [Abstract][Full Text] [Related]
16. Inflammatory bowel disease: tri-directional relationship between microbiota, immune system and intestinal epithelium.
Ahlawat S; Kumar P; Mohan H; Goyal S; Sharma KK
Crit Rev Microbiol; 2021 Mar; 47(2):254-273. PubMed ID: 33576711
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial dysfunction in inflammatory bowel disease alters intestinal epithelial metabolism of hepatic acylcarnitines.
Smith SA; Ogawa SA; Chau L; Whelan KA; Hamilton KE; Chen J; Tan L; Chen EZ; Keilbaugh S; Fogt F; Bewtra M; Braun J; Xavier RJ; Clish CB; Slaff B; Weljie AM; Bushman FD; Lewis JD; Li H; Master SR; Bennett MJ; Nakagawa H; Wu GD
J Clin Invest; 2021 Jan; 131(1):. PubMed ID: 33141762
[TBL] [Abstract][Full Text] [Related]
18. The role of microbiota-mitochondria crosstalk in pathogenesis and therapy of intestinal diseases.
Zhang Y; Zhang J; Duan L
Pharmacol Res; 2022 Dec; 186():106530. PubMed ID: 36349593
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory Bowel Diseases and Sarcopenia: The Role of Inflammation and Gut Microbiota in the Development of Muscle Failure.
Nardone OM; de Sire R; Petito V; Testa A; Villani G; Scaldaferri F; Castiglione F
Front Immunol; 2021; 12():694217. PubMed ID: 34326845
[TBL] [Abstract][Full Text] [Related]
20. Microbiota metabolite butyrate constrains neutrophil functions and ameliorates mucosal inflammation in inflammatory bowel disease.
Li G; Lin J; Zhang C; Gao H; Lu H; Gao X; Zhu R; Li Z; Li M; Liu Z
Gut Microbes; 2021; 13(1):1968257. PubMed ID: 34494943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
